Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
ConvaTec ( (GB:CTEC) ) just unveiled an update.
ConvaTec Group PLC announced a change in major holdings, with FIL Limited reducing its voting rights in the company. The voting rights held by FIL Limited decreased from 6.2098% to 5.9863%, crossing the 5% threshold downwards. This change in holdings may impact ConvaTec’s shareholder dynamics and influence within the company.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £305.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.
ConvaTec’s overall stock score reflects its strong financial performance, particularly its robust revenue growth and effective cash flow management. Technical analysis suggests positive momentum, although caution is warranted due to overbought signals. The company’s high valuation indicates strong market expectations, and recent corporate events reinforce its positive growth outlook. These factors position ConvaTec well in the medical equipment and supplies industry.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC is a UK-based company operating in the healthcare industry, primarily focusing on medical products and technologies. The company specializes in wound care, ostomy care, continence and critical care, and infusion devices, serving a global market.
Average Trading Volume: 6,446,468
Technical Sentiment Signal: Buy
Current Market Cap: £5.92B
For detailed information about CTEC stock, go to TipRanks’ Stock Analysis page.